Suzhou Ribo Life Science Co., Ltd. (HKG:6938)
64.70
+0.35 (0.54%)
At close: Apr 2, 2026
Suzhou Ribo Life Science Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 |
Cash & Equivalents | 406.75 | 183.62 | 212.35 | 238.12 | 105.11 |
Short-Term Investments | 1.59 | 1.54 | 2.92 | - | - |
Cash & Short-Term Investments | 408.34 | 185.16 | 215.27 | 238.12 | 105.11 |
Cash Growth | 120.53% | -13.98% | -9.60% | 126.55% | -51.45% |
Accounts Receivable | 5.46 | 3.47 | 0.01 | - | - |
Other Receivables | 32.97 | 31.28 | 38.58 | 0.92 | 1.46 |
Receivables | 38.43 | 34.75 | 38.59 | 0.92 | 1.46 |
Inventory | 54.93 | 42.72 | 45.6 | 19.87 | 10.17 |
Other Current Assets | 15.35 | 6.66 | 10.02 | 20.87 | 8.24 |
Total Current Assets | 517.05 | 269.29 | 309.48 | 279.79 | 124.98 |
Property, Plant & Equipment | 245.04 | 276.1 | 296.79 | 44.83 | 29.36 |
Other Intangible Assets | 76.83 | 92.47 | 108.42 | 88.49 | 99.86 |
Other Long-Term Assets | 0.89 | 12.99 | 1.57 | 18.96 | 14.63 |
Total Assets | 839.81 | 650.86 | 716.25 | 432.07 | 268.82 |
Accounts Payable | 11.63 | 24.23 | 23.27 | 5.61 | 6.71 |
Accrued Expenses | 106.61 | 26.13 | 26.51 | 12.33 | 7.09 |
Short-Term Debt | - | 12.43 | 12.1 | 76.08 | - |
Current Portion of Long-Term Debt | 373.03 | 214.18 | 205.18 | - | - |
Current Portion of Leases | 12.06 | 7.63 | 8.09 | - | - |
Current Income Taxes Payable | - | 1.24 | - | 0.62 | 0.38 |
Current Unearned Revenue | 78.99 | 81.02 | 14.49 | 12.28 | 10.27 |
Other Current Liabilities | 19.1 | 47.46 | 38.21 | 2.93 | 2.09 |
Total Current Liabilities | 601.41 | 414.31 | 327.85 | 109.85 | 26.53 |
Long-Term Debt | 149.38 | 172.28 | 163.71 | - | - |
Long-Term Leases | 15.6 | 22.36 | 25.66 | - | - |
Long-Term Unearned Revenue | 32.88 | 89.7 | 24.15 | 0.88 | 1.64 |
Other Long-Term Liabilities | 13.76 | 63.28 | 59.16 | 9.75 | - |
Total Liabilities | 813.04 | 761.93 | 600.53 | 120.49 | 28.17 |
Common Stock | 134.2 | 129.61 | 128.39 | 29.81 | 27.04 |
Additional Paid-In Capital | - | 1,283 | 1,046 | 683.49 | 480.52 |
Retained Earnings | - | -1,522 | -1,252 | -400.37 | -266.01 |
Comprehensive Income & Other | -228.14 | -0.88 | 182.34 | - | - |
Total Common Equity | -93.94 | -110.36 | 105.1 | 312.93 | 241.55 |
Minority Interest | 120.71 | -0.71 | 10.62 | -1.35 | -0.9 |
Shareholders' Equity | 26.77 | -111.07 | 115.72 | 311.58 | 240.65 |
Total Liabilities & Equity | 839.81 | 650.86 | 716.25 | 432.07 | 268.82 |
Total Debt | 550.07 | 428.88 | 414.74 | 76.08 | - |
Net Cash (Debt) | -141.73 | -243.72 | -199.47 | 162.04 | 105.11 |
Net Cash Growth | - | - | - | 54.16% | -51.45% |
Net Cash Per Share | -1.07 | -1.89 | -1.55 | 5.44 | 3.89 |
Filing Date Shares Outstanding | 134.2 | 134.2 | 128.39 | 29.81 | 27.04 |
Total Common Shares Outstanding | 134.2 | 129.61 | 128.39 | 29.81 | 27.04 |
Working Capital | -84.36 | -145.01 | -18.38 | 169.94 | 98.45 |
Book Value Per Share | -0.70 | -0.85 | 0.82 | 10.50 | 8.93 |
Tangible Book Value | -170.77 | -202.83 | -3.32 | 224.45 | 141.69 |
Tangible Book Value Per Share | -1.27 | -1.56 | -0.03 | 7.53 | 5.24 |
Buildings | 121.74 | 128.17 | 128.17 | - | - |
Machinery | 173.51 | 169.47 | 161.97 | 71.13 | 48.46 |
Leasehold Improvements | 4.28 | 4.28 | 4.28 | - | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.